Technical Data
K0005-16A
Kallikrein 13 (Biotin)
Description:
Applications:
Suitable for use in Western blot. Other applications have not been tested.

Recommended Dilutions:
Western Blot: 0.1-0.2ug/ml The detection limit is ~5ng/lane under reducing and non-reducing conditions.
Optimal dilutions to be determined by the researcher.

Hybridoma:
Produced in goats immunized with purified, NS0-derived, recombinant human Kallikrein 13 (rhKLK13; aa 19-262).

Storage and Stability:

Lyophilized powder may be stored at 4C for short-term only. Reconstitute to nominal volume by adding sterile 40-50% glycerol, aliquot and store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
50ug-20CBlue IceHumanGoat
Concentration:
~0.05mg/ml
Immunogen:
NS0-derived recombinant human rhKLK13.
Purity:
Purified by human KLK13 affinity chromatography.
Form
Supplied as a lyophilized powder from PBS and BSA. Labeled with Biotin. Reconstitute with 1ml 0.1% BSA in TBS to a concentration of 0.05mg/ml.
Specificity:
Recognizes human Kallikrein 13. Crossreactivity: 10% cross-reactivity with rhKallikrein 8, and less than 5% cross-reactivity with rhKallikrein 11, rhKallikrein 14, and rhKallikrein 15.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.